Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided for the purpose of scientific exchange.

The website is not country specific and may therefore contain information that is not applicable in your country, thus you may find information concerning study drugs or therapeutic uses that have not been approved by drug regulatory agencies. This website is not intended to promote in any way, any use, either approved, or unapproved, of a Novo Nordisk product or of any other product or serve as basis for any treatment decision or action. Please always refer to Summary of Product Characteristics (product label) as approved by regulatory authorities in your country or contact Novo Nordisk for further information.

Furthermore, the site is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. Only a physician can determine whether a specific product is correct for a particular patient. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site.

By accessing this website you accept this legal notice and expressly confirm your status as a healthcare professional.

ECO 2021 May 10 - 13

Efficacy and Safety of Semaglutide 2.4 mg Once-Weekly in Adults with Overweight or Obesity and Type 2 Diabetes (STEP 2)

Melanie Davies1; Louise Færch2; Ole Kleist Jeppesen2; Arash Pakseresht2; Sue D. Pedersen3; Leigh Perreault4; Julio Rosenstock5; Iichiro Shimomura6; Adie Viljoen7; Thomas Wadden8; Ildiko Lingvay9;
1University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, UK; 2Novo Nordisk A/S, Søborg, Denmark; 3C-ENDO Diabetes & Endocrinology Clinic Calgary, Calgary, AB, Canada; 4University of Colorado Hospital, Denver, CO, USA; 5Dallas Diabetes Research Center at Medical City, Dallas, TX, USA; 6Osaka University, 2-2-B5, Yamada-oka, Suita, Osaka, Japan; 7Lister Hospital, Stevenage, UK; 8University of Pennsylvania, Philadelphia, PA, USA; 9UT Southwestern Medical Center, Dallas, TX, US;